Jiangsu Hengrui Medicine’s $87.75 Million License Agreement with CrystalGenomics

Ambrogio Visconti

Sidley Austin LLP advised Jiangsu Hengrui Medicine Co., Ltd. in entering into a license agreement with CrystalGenomics, Inc. Crystal Genomics (KOSDAQ: 083790), a South Korea-based biopharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now